 L&T and GA-ASI Announce Strategic Partnership for MALE RPAS Manufacture in India
L&T and GA-ASI Announce Strategic Partnership for MALE RPAS Manufacture in India NATCO announces launch of its Everolimus tablets, 1 mg, (generic of Zortress®)
NATCO announces launch of its Everolimus tablets, 1 mg, (generic of Zortress®) Exhicon Global Development Ltd inks MoU with NIMA
Exhicon Global Development Ltd inks MoU with NIMA RateGain and FLYR Partner to Power Smarter Hotel Pricing with Integrated Rate Shopping
RateGain and FLYR Partner to Power Smarter Hotel Pricing with Integrated Rate Shopping JUSTO Secures ₹1,545+ Crore in New Mandates, Cumulative Portfolio Crosses ₹4,500 Crore
JUSTO Secures ₹1,545+ Crore in New Mandates, Cumulative Portfolio Crosses ₹4,500 Crore 
              Skipper has reported in-line performance in 3QFY17. Its net revenue grew by 15.8% YoY to Rs4306mn, aided by healthy performance in all operating segments. Its EBITDA stood at Rs570mn, while reported EBITDA margin came in at 13.2% in 3QFY17 compared to 13.3% in 3QFY16. On the back of better execution, its PAT surged by 195% YoY to Rs223 mn. We continue to believe that a sizeable order book, huge imminent opportunity and diversification into PVC business firmly place Skipper on a higher growth trajectory. We reiterate our BUY recommendation on the stock with an unrevised Target Price of Rs187.